|
|
||||||||
1 Department of Physiology and Pharmacology, Loma Linda University, Loma Linda 92350; and 2 Division of Physiology, Department of Medicine, University of California, San Diego, La Jolla, California 92093-0623
| |
ABSTRACT |
|---|
|
|
|---|
Vascular endothelial
growth factor (VEGF) is a hypoxia-inducible angiogenic mitogen.
However, chronic hypoxia is generally not found to increase mammalian
skeletal muscle capillarity. We sought to determine the effect of
chronic hypoxia (8 wk, inspired O2 fraction = 0.12) on
skeletal muscle gene expression of VEGF, its receptors (flt-1 and
flk-1), basic fibroblast growth factor, and transforming growth
factor-
1. Wistar rats were exposed to chronic hypoxia
(n = 12) or room air (n = 12). After
the exposure period, six animals from each group were subjected to a
single 1-h treadmill exercise bout (18 m/min on a 10° incline) in
room air while the remaining six animals served as rest controls.
Morphological analysis revealed that chronic hypoxia did not increase
skeletal muscle capillarity. Northern blot analyses showed that chronic hypoxia decreased resting VEGF, flt-1, and flk-1 mRNA by 23, 68, and
42%, respectively (P < 0.05). The VEGF mRNA response
to exercise was also decreased (4.1- and 2.7-fold increase in room air
and chronic hypoxia, respectively, P < 0.05). In
contrast, neither transforming growth factor-
1 nor basic
fibroblast growth factor mRNA was significantly altered by chronic
hypoxia. In conclusion, prolonged exposure to hypoxia attenuated gene
expression of VEGF and its receptors flt-1 and flk-1 in rat
gastrocnemius muscle. These findings may provide an explanation for the
lack of mammalian skeletal muscle angiogenesis that is observed after
chronic hypoxia.
Northern blot analysis; angiogenesis; transforming growth
factor-
1; basic fibroblast growth factor
| |
INTRODUCTION |
|---|
|
|
|---|
THE EFFECTS OF CHRONIC HYPOXIA have been well documented in humans and animals (1). Initial studies in skeletal muscle reported an increase in capillary density in response to chronic hypoxia. However, later studies revealed that the observed increase in capillary density was not due to new capillary growth but, rather, a reduction in muscle fiber area (attributed to muscle atrophy or tissue shrinkage associated with the histological technique) (1, 39). Similarly, in other cases where increases in muscle capillarity were observed, factors such as the cold temperature (associated with high altitude) (2) and normal growth and development (34) were found to contribute to capillary growth. Therefore, it has widely been accepted that chronic hypoxia alone does not induce skeletal muscle angiogenesis. Indeed, Banchero (1), in 1987, after reviewing the bulk of existing evidence, concluded that "skeletal muscle capillarity does not respond to simple normothermic hypoxia." Nevertheless, more recently it has been reported that chronic hypoxia increases skeletal muscle capillarity (as measured by capillary-to-fiber ratio) in several avian species (20, 23, 28) and possibly in the rat (10). Moreover, chronic hypoxia is also found to increase the number of capillaries in the mammalian brain (4) and placenta (37). Therefore, whether chronic hypoxia is capable of inducing angiogenesis remains controversial.
Within the last decade, vascular endothelial growth factor (VEGF) has emerged as an important hypoxia-inducible angiogenic mitogen (13). VEGF is expressed by a wide variety of cell types and is known to increase vascular permeability, endothelial cell proliferation, migration, and angiogenesis in vivo (12). The VEGF receptors flt-1 and flk-1 are found almost exclusively on vascular endothelial cells, making VEGF an endothelium-specific mitogen (12). There is little question regarding the importance of VEGF in the initiation of angiogenesis, and its essential role is emphasized by the fact that gene inactivation of VEGF or its receptors results in an early embryonic death (12).
Hypoxia has been found to be an important stimulus that induces
transcriptional induction of VEGF and increases posttranscriptional stabilization of VEGF mRNA (9, 25). In addition to
hypoxia, several cytokines (interleukin-1
, -10, and -13), growth
factors [basic fibroblast growth factor (bFGF) and transforming growth factor-
1 (TGF-
1)], and vasoactive
molecules [nitric oxide (NO) and adenosine] have been shown to
regulate VEGF gene expression (3, 12, 30). Several studies
have now shown that VEGF mRNA is increased in skeletal muscle after
acute exercise and that acute hypoxic exercise further augments the
VEGF mRNA response (5, 18, 32). Similarly, electrical
nerve stimulation, which is frequently used to simulate exercise, is
also found to increase VEGF mRNA levels (19). Indeed,
exercise training and electrical stimulation are well known to increase
skeletal muscle capillarity, indicating that VEGF is likely to play an
important role in skeletal muscle angiogenesis.
Because VEGF is believed to be the primary mediator in hypoxia-induced
angiogenesis, it seems paradoxical that increases in capillarity are
not routinely found in mammalian skeletal muscle exposed to chronic
hypoxia. Therefore, we sought to determine what effect chronic hypoxia
might have on the gene expression of VEGF and its receptors (flt-1 and
flk-1). Gene expression of two other growth factors (bFGF and
TGF-
1), both of which demonstrate angiogenic activity
and may also regulate VEGF, was also studied.
In this study we demonstrate, using quantitative Northern blot
analysis, that rats exposed to chronic hypoxia, at a level that
increases muscle VEGF mRNA acutely (5), decreased the resting mRNA levels of VEGF, flt-1, and flk-1 in the gastrocnemius muscle. In addition, chronic hypoxia did not increase the
capillary-to-fiber ratio or the number of capillaries around a fiber in
this muscle. Chronic hypoxia also attenuated the VEGF mRNA response to
exercise. In contrast, neither resting nor exercise-induced levels of
bFGF and TGF-
1 mRNAs were significantly altered by
chronic hypoxia.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
This study was approved by the University of California, San Diego, Animal Subjects Committee and the Loma Linda University Animal Research Committee. Twenty-four 9- to 10-wk-old female Wistar rats were randomly assigned to room air (n = 12) or chronic hypoxia [n = 12, inspired O2 fraction (FIO2) = 0.12] for 8 wk. This FIO2 was based on prior work showing acute increases in VEGF mRNA in skeletal muscle of rats exposed to this level of O2 for just 1 h (5). After 8 wk at the assigned FIO2, six animals from each group were subjected to a single 1-h exercise bout while the remaining six animals served as resting (i.e., basal) controls. This strategy allowed us to examine the effect of chronic hypoxia on the basal, as well as exercised-induced, gene expression levels in skeletal muscle.
Environmental conditions. Normobaric hypoxia was maintained using an environmental chamber that electronically controlled the FIO2 level by mixing air and N2 from tanks. Separate O2 and CO2 analyzers independently monitored and continuously recorded O2 and CO2 levels throughout the 8-wk exposure period. FIO2 was maintained at 0.12, and CO2 levels were kept below 0.5% by using soda lime. The environmental chamber also electronically controlled and maintained normal ambient temperature (22-24°C) within the chamber. All animals were visually inspected daily for abnormal and normal behavior, food and water consumption, and overall health. Cages were cleaned and bedding was replaced every 2-3 days or as needed between the scheduled changes. Animals were provided standard rat food and water ad libitum and were confined to their cages (2-3/cage) throughout the 8-wk period.
Single exercise bout. After the 8-wk exposure period, six animals from each group were randomly selected to perform the single exercise bout. The rats were allowed to familiarize themselves with the rodent treadmill (Omnipacer model CL-4, Omnitech, Columbus, OH) for 5-10 min at a slow speed (5 m/min), and then they ran for 1 h at 18 m/min on a 10° incline in room air. To motivate the rats and keep them running, a shock grid and air jets were utilized at the rear of the treadmill.
Surgical procedure and vascular perfusion protocol.
After they completed the exercise bout, the rats were immediately
anesthetized with pentobarbital sodium (Nembutal, 50 mg/kg ip). A
corneal reflex or toe pinch response was used to ensure adequate
anesthesia; then the entire left gastrocnemius muscle was surgically
removed and flash frozen using liquid nitrogen. Muscles were stored at
80°C until processed for Northern blot analysis.
RNA isolation and Northern blot analysis.
Total cellular RNA was isolated from the whole left medial
gastrocnemius muscle by the method of Chomczynski and Sacchi
(7). RNA (10 µg) preparations were quantitated by
absorbance at 260 nm, and intactness was assessed by ethidium bromide
staining of RNA that was separated by electrophoresis using a 6.6%
formaldehyde-1% agarose gel. Fractionated RNA was transferred to a
Zeta probe membrane (Bio-Rad, Hercules, CA), cross-linked to the nylon
membrane by ultraviolet irradiation, and then stored at 4°C. Blots
were then probed with oligolabeled [
-32P]dCTP cDNA
probes, which had specific activities of
1 × 109
disintegrations · min
1 · µg
DNA
1 (11). The rat VEGF probe is a 0.9-kb
cDNA PstI/SmaI insert cloned into pBluescript II
KS(+) vector. The 1.2-kb rat KDR/Flk-1 cDNA EcoRI insert of
pUC18 and the 0.6-kb rat Flt-1 cDNA EcoRI/HindIII insert of pUC119 were kindly provided by Dr. Masabumi Shibuya (42). The rat TGF-
1 cDNA probe is a
0.985-kb HindIII/XbaI insert cloned into
pBluescript II KS(+) vector. The bFGF probe is a 1-kb XhoI
fragment of human bFGF cDNA. Prehybridization and hybridizations were
performed in 50% formamide, 10× saline-sodium citrate (SSC, 20× SSC
is 0.3 M sodium chloride and 0.3 M sodium citrate), 5× Denhardt's
solution (100× Denhardt's solution is 2% Ficoll and 2%
polyvinylpyrrolidone), 50 mM sodium phosphate (pH 6.5), 1% SDS, and
250 µg/ml sonicated salmon sperm DNA at 42°C. Blots were washed
with 2× SSC and 0.1% SDS at room temperature and 0.1× SSC and 0.1%
SDS at 65°C for VEGF mRNA, 60°C for bFGF mRNA, and 50°C for
TGF-
1, Flk-1, and Flt-1 mRNAs. Blots were exposed to
X-OMAT AR-5 X-ray film (Eastman Kodak, New Haven, CT) using a Cronex Lighting Plus screen at
80°C. Autoradiographs were quantitated via
a computer densitometry software package (Gel-Pro Analyzer, Media
Cybernetics, Silver Spring, MD) and normalized to 18S rRNA levels.
Data analysis. Values are means ± SE. ANOVA and Student's t-test were used to determine significance. Significance was accepted at the 0.05 confidence level.
| |
RESULTS |
|---|
|
|
|---|
As expected, rats exposed to chronic hypoxia weighed significantly
less than rats exposed to room air (230 ± 3.7 vs. 243 ± 4.2 g, P < 0.05; Fig.
1). Chronic hypoxia did not increase
skeletal muscle capillarity in the rat gastrocnemius muscle (Fig.
2). This is also evident in Table
1, where morphological analyses revealed no significant difference in skeletal muscle capillarity (i.e., number
of capillaries around a fiber and capillary-to-fiber ratio).
|
|
|
Northern blot analyses of the effect of chronic hypoxia on resting and
exercise-induced VEGF, TGF-
1, bFGF, flt-1, and flk-1 mRNA levels are shown in Fig. 3.
Densitometric analyses, compared with room air resting values, which
were normalized to 1.0 (Fig. 4), revealed
that chronic hypoxia lowered resting levels of VEGF mRNA (1.0 ± 0.03 and 0.77 ± 0.08 in room air and chronic hypoxia, respectively, P < 0.05), whereas bFGF (1.0 ± 0.05 and 1.11 ± 0.04 in room air and chronic hypoxia,
respectively, not significant) and TGF-
1 (1.0 ± 0.10 and 0.68 ± 0.06 in room air and chronic hypoxia,
respectively, not significant) mRNA levels were not significantly altered.
|
|
We also confirmed that VEGF mRNA increased fourfold from rest to
exercise (Fig. 4) in room air-breathing rats (1.0 ± 0.03 and
4.09 ± 0.69 at rest and after a single exercise bout,
respectively, P < 0.05), as previously reported by
Breen et al. (5). However, we found that chronic hypoxia
attenuated this response (4.1- and 2.7-fold in room air and chronic
hypoxia, respectively, P < 0.05), suggesting that the
VEGF gene response to exercise has been downregulated. Although neither
TGF-
1 (P = 0.06) nor bFGF mRNA
(P = 0.19) increased significantly in room
air-breathing animals after exercise, a small but statistically
significant increase in bFGF mRNA was found after exercise in animals
exposed to chronic hypoxia compared with those exposed to room air
(Fig. 4).
Chronic hypoxia also decreased resting levels of flt-1 and flk-1 mRNA
(Fig. 5). Interestingly, flt-1 and flk-1
mRNA exhibited divergent responses to exercise. Flk-1 mRNA decreased
with exercise in animals exposed to room air and chronic hypoxia, but
this decrease was statistically significant only in the animals exposed
to room air (1.0 ± 0.10 and 0.47 ± 0.05 at rest and after a
single exercise bout, respectively, P < 0.05). In
contrast, flt-1 mRNA tended to increase with exercise, but this was not
statistically significant in the animals exposed to room air or chronic
hypoxia.
|
| |
DISCUSSION |
|---|
|
|
|---|
The principal finding in this study is that chronic hypoxia decreases the gene expression of VEGF and its receptors flt-1 and flk-1 in mammalian skeletal muscle. Exposure to chronic hypoxia also attenuated, but did not abolish, the VEGF mRNA response to a single bout of exercise. These findings suggest that chronic hypoxia alters the gene expression of VEGF and its receptors in a manner that is unfavorable to capillary growth and may explain why an increase in mammalian skeletal muscle angiogenesis is not generally observed after chronic hypoxia.
Chronic hypoxia and muscle morphology.
In most studies, chronic hypoxia or high-altitude exposure caused a
reduction in muscle fiber area (usually attributed to muscle atrophy).
On morphological analysis (Table 1), we did not find a decrease in the
muscle fiber area (fiber cross-sectional area), nor did we find a
concomitant increase in capillary density. Although, at first, the lack
of decrease in fiber size may seem inconsistent, others who have
exposed rats to a similar level of hypoxia
(FIO2 = 0.12 or ~4,000-m altitude) have also not found significant
decreases in fiber cross-sectional area (40). Indeed, most
studies (6) that have found a significant decrease in fiber cross-sectional area were conducted at altitudes >5,000 m
(equivalent to FIO2
0.10). Therefore, it
is not surprising (given the level of hypoxia) that we did not find a
reduction in fiber cross-sectional area. However, consistent with most
studies in mammals, we found that chronic hypoxia did not increase the number of capillaries around a fiber or the capillary-to-fiber ratio,
indicating that new capillaries had not been formed. One explanation
for the lack of capillary change could be that, to the extent
intracellular hypoxia is the stimulus for VEGF gene expression,
intracellular PO2 was, in fact, not
sufficiently reduced by chronic hypoxia to provide an adequate
stimulus. However, our laboratory's prior work showing that acute 1-h
exposure of similar rats to the same FIO2
used here (0.12) did, in fact, produce an significant (>2-fold)
increase in VEGF mRNA (5) would argue against this possibility.
Chronic hypoxia and VEGF gene expression. It is well known that hypoxia induces VEGF gene expression. This increase is now known to be mediated through an O2-responsive transcriptional factor, hypoxia inducible factor-1 (HIF-1) (25, 38). Although some studies (8, 41), mostly in the lung, have reported that chronic hypoxia increases VEGF gene expression, a recent study in the mouse brain showed that VEGF protein and gene expression return to basal levels after 7 days of continuous hypoxia (21). This finding is consistent with our data in the rat gastrocnemius muscle (Figs. 3 and 4) and suggests that a mechanism exists by which chronic hypoxia can downregulate VEGF gene expression. In support of this observation, Levy (24) recently demonstrated that transcription of VEGF (through HIF-1) is inhibited or severely blunted in human hepatoma (Hep 3B) cells and rat cardiomyocytes (H9c2) preconditioned to a hypoxic environment (i.e., grown in culture under hypoxia). Similarly, cultured neurons preconditioned to hypoxia also demonstrate decreased HIF-1 binding activity (35). Moreover, in cultured aortic smooth muscle cells, NO, which is believed to be important in the vasodilatory response to hypoxia, has also been shown to inhibit hypoxic induction of VEGF by decreased HIF-1 binding activity (26). Therefore, although acute hypoxia has been found to induce VEGF gene expression, prolonged exposure to hypoxia (i.e., weeks) appears to eventually downregulate transcriptional activation of VEGF in a variety of cells and tissues.
However, recent studies by Benoit et al. (3) and Gavin et al. (15) have demonstrated that NO is important in the VEGF gene response to exercise in the rat gastrocnemius. Therefore, whether NO, after chronic hypoxic exposure, is truly involved in attenuating skeletal muscle VEGF gene expression is unclear. Additionally, whether skeletal muscle VEGF protein levels are also decreased after chronic hypoxia is also unknown. Although it is true that changes in mRNA do not necessarily translate to changes at the protein level, given the importance of VEGF in angiogenesis, it would be surprising to find a relationship between VEGF mRNA and angiogenesis without a resultant change at the protein level.Exercise-induced gene expression and chronic hypoxia. Exercise induces a number of changes within the cardiovascular and skeletal muscle systems, such as increased blood flow, changes in local metabolite concentrations, increased mechanical stresses, and acid-base changes. However, the mechanism by which genes are induced or regulated in response to exercise remains poorly understood. It is well known that exercise produces a substantial drop in extracellular (venous) and, perhaps more importantly, intracellular skeletal muscle PO2 (31). Therefore, it is possible that a local reduction in PO2 may regulate VEGF transcription in response to exercise. Accordingly, if hypoxic induction of VEGF is attenuated by chronic hypoxia due to decreased HIF-1 binding activity, exercise-induced gene expression may also be attenuated. Indeed, the VEGF gene response to exercise was attenuated by chronic hypoxia (Fig. 4). This is consistent with the notion that a local hypoxia might be acting as a stimulus that induces VEGF gene expression.
VEGF receptors (Flt-1 and Flk-1) and exercise.
Both flt-1 and flk-1 receptors have been shown to be important in
angiogenesis (12). Therefore, our finding that chronic hypoxia attenuates resting levels of flt-1 and flk-1 mRNA is consistent with the notion that chronic hypoxia alters skeletal muscle in a manner
that is unlikely to favor capillary growth. Perhaps of greater interest
is the finding that the flt-1 and flk-1 responded divergently to
exercise, which is consistent with the observation that hypoxia at the
transcriptional level appears to differentially regulate these VEGF
receptors. Indeed, Sandner et al. (36) reported that
hypoxia increases flt-1 mRNA, but not flk-1 mRNA, in the rat liver and
lungs and, Gerber et al. (17) demonstrated that gene
expression of flt-1, but not flk-1, is regulated through HIF-1. In our
study, flt-1 mRNA levels tended to increase with exercise, which
supports the notion that hypoxia at the tissue level may play a role in
regulating gene transcription in response to exercise. Indeed, other
studies have found flt-1 mRNA to significantly increase with exercise
(14, 16). The fact that flt-1 mRNA was not increased
significantly in our animals may be explained by the time at which
muscles were sampled. In contrast to VEGF, in which peak gene
expression occurs rapidly (within 0-2 h) in response to exercise
(5), the peak VEGF receptor gene response to exercise may
not occur until several hours after exercise (16). In this
study, muscles were removed immediately (<20 min) after exercise,
whereas the muscles in the studies that demonstrated a significant rise
in flt-1 mRNA were removed
1 h after exercise (allowing greater time
for mRNA levels to increase after exercise). Given the importance of
VEGF and its receptors in angiogenesis, it seems reasonable to believe
that at least one VEGF receptor (e.g., flt-1), if not both, is involved
in exercise-induced angiogenesis.
TGF-
1 and bFGF gene expression.
Breen et al. (5) showed a small, but significant, increase
in TGF-
1 and bFGF mRNA with exercise in the rat
gastrocnemius. Although we do not report a significant increase in
TGF-
1 (P = 0.06) or bFGF in our
experimental animals, it is evident in Fig. 4 that TGF-
1
mRNA levels tended to increase with exercise, and P = 0.06 is on the borderline of the standard level of significance. These
findings are consistent with those of others (15)
demonstrating only a modest increase in TGF-
1 mRNA and
no changes in bFGF mRNA in response to exercise. Given the relatively
small gene responses in TGF-
1 and bFGF in all three
studies, it seems reasonable to believe that neither growth factor is
likely to play a significant role in the acute angiogenic response to
exercise. Nonetheless, it is important to note that both growth factors
have been shown to be important angiogenic regulators. Moreover,
chronic electrical nerve stimulation (>3 wk) has been shown to
increase bFGF protein in skeletal muscle (29), suggesting
that bFGF may be involved in the angiogenic response to repeated
exercise bouts. However, the present results suggest that it is
unlikely that TGF-
1 or bFGF plays a significant role in
regulation of skeletal muscle capillarity in chronic hypoxia.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Harrieth Wagner, Nick Busan, Jeff Struthers, Larnele Hazelwood, and Pete Agey for technical assistance.
| |
FOOTNOTES |
|---|
This study was funded by National Heart, Lung, and Blood Institute Grant HL-17731. I. M. Olfert received financial support from the Department of Physiology and Pharmacology, School of Graduate Studies, Loma Linda University.
Address for reprint requests and other correspondence: I. M. Olfert, UCSD Medicine 0623A, Div. of Physiology, 9500 Gilman Dr., La Jolla, CA 92093-0623.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 12 May 2000; accepted in final form 20 October 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Banchero, N.
Cardiovascular responses to chronic hypoxia.
Annu Rev Physiol
49:
465-476,
1987[ISI][Medline].
2.
Banchero, N,
Kayar S,
and
Lechner A.
Increased capillarity in skeletal muscle of growing guinea pigs acclimated to cold and hypoxia.
Respir Physiol
62:
245-255,
1985[ISI][Medline].
3.
Benoit, H,
Jordan M,
Wagner H,
and
Wagner PD.
Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression.
J Appl Physiol
86:
1513-1518,
1999
4.
Boero, JA,
Ascher J,
Arregui A,
Rovainen C,
and
Woolsey TA.
Increased brain capillaries in chronic hypoxia.
J Appl Physiol
86:
1211-1219,
1999
5.
Breen, EC,
Johnson EC,
Wagner H,
Tseng H-M,
Sung LA,
and
Wagner PD.
Angiogenic growth factor mRNA responses in muscle to a single bout of exercise.
J Appl Physiol
81:
355-361,
1996
6.
Cerretelli, P,
and
Hoppeler H.
Morphologic and metabolic responses to chronic hypoxia: the muscle system.
In: Handbook of Physiology: Environmental Physiology. Bethesda, MD: Am. Physiol. Soc, 1996, sect. 4, vol. II, chapt. 50, p. 1155-1181.
7.
Chomczynski, P,
and
Sacchi N.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.
Anal Biochem
162:
156-159,
1987[ISI][Medline].
8.
Christou, H,
Yoshida A,
Arthur V,
Morita T,
and
Kourembanas S.
Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension.
Am J Respir Cell Mol Biol
18:
768-776,
1998
9.
Claffey, KP,
Shih S-C,
Mullen A,
Dziennis S,
Cusick JL,
Abrams KR,
Lee SW,
and
Detmar M.
Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability.
Mol Biol Cell
9:
469-481,
1998
10.
Deveci, D,
Egginton S,
and
Marshall JM.
Relationship between capillary angiogenesis and muscle fibre size in response to chronic hypoxia in rats (Abstract).
J Physiol (Lond)
515:
145P,
1999.
11.
Feinberg, AP,
and
Vogelstein B.
A technique for radiolabeling DNA restriction endonuclease fragments to a high specific activity.
Anal Biochem
132:
6-13,
1983[ISI][Medline].
12.
Ferrara, N,
and
Davis-Smyth T.
The biology of vascular endothelial growth factor.
Endocr Rev
18:
4-25,
1997
13.
Folkman, J,
and
Klagsbrun M.
Angiogenic factors.
Science
235:
442-447,
1987
14.
Gavin, TP,
Spector DA,
Wagner H,
Breen EC,
and
Wagner PD.
Effect of captopril on skeletal muscle angiogenic growth factor responses to exercise.
J Appl Physiol
88:
1690-1697,
2000
15.
Gavin, TP,
Spector DA,
Wagner H,
Breen EC,
and
Wagner PD.
Nitric oxide synthase inhibition attenuates the skeletal muscle VEGF mRNA response to exercise.
J Appl Physiol
88:
1192-1198,
2000
16.
Gavin, TP,
Wagner H,
and
Wagner PD.
VEGF receptor (FLT-1) mRNA response to acute exercise and nitric oxide synthase inhibition (Abstract).
FASEB J
14:
A324,
2000.
17.
Gerber, H-P,
Condorelli F,
Park J,
and
Ferrara N.
Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes.
J Biol Chem
272:
23659-23667,
1997
18.
Gustafsson, T,
Puntschart A,
Kaijser L,
Jansson E,
and
Sundberg CJ.
Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle.
Am J Physiol Heart Circ Physiol
276:
H679-H685,
1999
19.
Hang, J,
Kong L,
Gu J-W,
and
Adair TH.
VEGF gene expression is upregulated in electrically stimulated rat skeletal muscle.
Am J Physiol Heart Circ Physiol
269:
H1827-H1831,
1995
20.
Hepple, RT,
Agey PJ,
Hazelwood L,
Szewczak JM,
MacMillen RE,
and
Mathieu-Costello O.
Increased capillarity in leg muscle of finches living at altitude.
J Appl Physiol
85:
1871-1876,
1998
21.
Kuo, N-T,
Benhayon D,
Przybylski RJ,
Martin R,
and
LaManna JC.
Prolonged hypoxia increases vascular endothelial growth factor mRNA and protein in adult mouse brain.
J Appl Physiol
86:
260-264,
1999
22.
Laughlin, MH,
and
Armstrong RB.
Muscular blood flow distribution patterns as a function of running speed in rats.
Am J Physiol Heart Circ Physiol
243:
H296-H306,
1982
23.
Leon-Velarde, F,
Sanchez A,
Bigard AX,
Brunet A,
Lesty C,
and
Monge C.
High altitude tissue adaptation in Andean coots
capillarity, fibre type and enzymatic activities of skeletal muscle.
J Comp Physiol [B]
163:
52-58,
1993[Medline].
24.
Levy, AP.
A cellular paradigm for the failure to increase vascular endothelial growth factor in chronically hypoxic states.
Coronary Artery Dis
10:
427-430,
1999[ISI][Medline].
25.
Levy, AP,
Levy NS,
Wegner S,
and
Goldberg MA.
Transcriptional regulation of rat vascular endothelial growth factor gene by hypoxia.
J Biol Chem
270:
13333-13340,
1995
26.
Liu, Y,
Christou H,
Morita T,
Laughner E,
Semenza G,
and
Kourembanas S.
Carbon monoxide and nitric oxide suppress the hypoxic induction of vascular endothelial growth factor gene via the 5' enhancer.
J Biol Chem
273:
15257-15262,
1998
27.
Mathieu-Costello, O.
Capillary tortuosity and degree of contraction or extension of skeletal muscle.
Microvasc Res
33:
98-117,
1987[ISI][Medline].
28.
Mathieu-Costello, O,
and
Agey P.
Chronic hypoxia affects capillary density and geometry in pigeon pectoralis muscle.
Respir Physiol
109:
39-52,
1997[ISI][Medline].
29.
Morrow, NG,
Kraus WE,
Moore JW,
Williams RS,
and
Swain JL.
Increased expression of fibroblast growth factor in a rabbit skeletal muscle model of exercise conditioning.
J Clin Invest
85:
1816-1820,
1990.
30.
Pedram, A,
Razandi M,
Hu R-M,
and
Levin E.
Vasoactive peptides modulate vascular endothelial cell growth factor production and endothelial cell proliferation and invasion.
J Biol Chem
272:
17097-17103,
1997
31.
Richardson, RS,
Noyszewski EA,
Kendrick KF,
Leigh JS,
and
Wagner PD.
Myoglobin O2 desaturation during exercise: evidence of limited O2 transport.
J Clin Invest
96:
1916-1926,
1995.
32.
Richardson, RS,
Wagner H,
Mudaliar SRD,
Henry R,
Noyszewski EA,
and
Wagner PD.
Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise.
Am J Physiol Heart Circ Physiol
277:
H2247-H2252,
1999
33.
Richardson, RS,
Wagner H,
Mudaliar SRD,
Saucedo E,
Henry R,
and
Wagner PD.
Exercise adaptation attenuates VEGF gene expression in human skeletal muscle.
Am J Physiol Heart Circ Physiol
279:
H772-H778,
2000
34.
Ripoll, E,
Sillau A,
and
Banchero N.
Changes in the capillarity of skeletal muscle in the growing rat.
Pflügers Arch
380:
153-158,
1979[ISI][Medline].
35.
Ruscher, K,
Isaev N,
Trendelenburg G,
Weih M,
Iurato L,
Meisel A,
and
Dirnagl U.
Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons.
Neurosci Lett
254:
117-120,
1998[ISI][Medline].
36.
Sandner, P,
Wolf K,
Bergmaier U,
Gess B,
and
Kurtz A.
Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro.
Kidney Int
51:
448-453,
1997[ISI][Medline].
37.
Scheffen, I,
Kaufmann P,
Philippens L,
Leiser R,
Geisen C,
and
Mottaghy K.
Alterations of the fetal capillary bed in the guinea pig placenta following long-term hypoxia.
Adv Exp Med Biol
277:
779-790,
1990[Medline].
38.
Semenza, GL,
Agani F,
Iyer N,
Jiang B-H,
Leung S,
Wiener C,
and
Yu A.
Hypoxia-inducible factor-1: from molecular biology to cardiopulmonary physiology.
Chest
114:
40S-45S,
1998
39.
Sillau, A,
Aquin L,
Bui M,
and
Banchero N.
Chronic hypoxia does not affect guinea pig skeletal muscle capillarity.
Pflügers Arch
386:
39-45,
1984.
40.
Sillau, A,
and
Banchero N.
Effects of hypoxia on capillary density and fiber composition in rat skeletal muscle.
Pflügers Arch
370:
227-232,
1977[ISI][Medline].
41.
Tuder, RM,
Flook BE,
and
Voelkel NF.
Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia.
J Clin Invest
95:
1798-1807,
1995.
42.
Yamane, A,
Seetharam L,
Yamaguchi S,
Gotoh N,
Takahashi T,
Neufeld G,
and
Shibuya M.
A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (flt-1 and KDR/Flk-1).
Oncogene
9:
2683-2690,
1994[ISI][Medline].
This article has been cited by other articles:
![]() |
N. A. Ryan, K. A. Zwetsloot, L. M. Westerkamp, R. C. Hickner, W. E. Pofahl, and T. P. Gavin Lower skeletal muscle capillarization and VEGF expression in aged vs. young men J Appl Physiol, January 1, 2006; 100(1): 178 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Yau, G. Li, Y. Zhang, R. D. Weisel, D. A.G. Mickle, and R.-K. Li Vascular Endothelial Growth Factor Receptor Upregulation in Response to Cell-Based Angiogenic Gene Therapy Ann. Thorac. Surg., June 1, 2005; 79(6): 2056 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Waters, S. Rotevatn, P. Li, B. H. Annex, and Z. Yan Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle Am J Physiol Cell Physiol, November 1, 2004; 287(5): C1342 - C1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lundby, H. Pilegaard, J. L. Andersen, G. van Hall, M. Sander, and J. A. L. Calbet Acclimatization to 4100 m does not change capillary density or mRNA expression of potential angiogenesis regulatory factors in human skeletal muscle J. Exp. Biol., October 15, 2004; 207(22): 3865 - 3871. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Prior, H. T. Yang, and R. L. Terjung What makes vessels grow with exercise training? J Appl Physiol, September 1, 2004; 97(3): 1119 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Gavin and P. D. Wagner Acute ethanol increases angiogenic growth factor gene expression in rat skeletal muscle J Appl Physiol, March 1, 2002; 92(3): 1176 - 1182. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Olfert, E. C. Breen, O. Mathieu-Costello, and P. D. Wagner Skeletal muscle capillarity and angiogenic mRNA levels after exercise training in normoxia and chronic hypoxia J Appl Physiol, September 1, 2001; 91(3): 1176 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. McClelland and G. A. Brooks Changes in MCT 1, MCT 4, and LDH expression are tissue specific in rats after long-term hypobaric hypoxia J Appl Physiol, April 1, 2002; 92(4): 1573 - 1584. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |